Sign inJoin waitlistJoin the waitlist

SA

Sady Alpizar

Physician · SADY A ALPIZAR MD PA

Credentials: · ·

History

SADY A ALPIZAR MD PA
Present

Internal Medicine
University of South Florida Morsani College of Medicine
2007–2010
Doctor of Medicine
2003–2007

Research

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study
Journal of the European Academy of Dermatology and Venereology · 2021 · 45 citations
Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis
Journal of Allergy and Clinical Immunology Global · 2024 · 43 citations
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents
Dermatology and Therapy · 2022 · 35 citations

VL
Vivian Laquer
3 papers
Jonathan Silverberg
2 papers
RS
Robert Sidbury
2 papers
Afsaneh Alavi
1 paper
AP
Amanda Paschke
1 paper
DB
Dana Byrne
1 paper
DA
Duane Anderson
1 paper
GC
Gene Colice
1 paper
GT
Gretel Trullenque
1 paper
HP
Heather Platt
1 paper
JC
Jose Cardona
1 paper
LS
Lawrence Sher
1 paper

Clinical trials

Phase III Long-Term Extension Study With Dexpramipexole
Principal investigator · Terminated · Phase 3
Areteia Therapeutics
2024–2025
Tezepelumab Home Use Study
Principal investigator · Completed · Phase 3
AstraZeneca
2019–2020
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Site PI · Recruiting · Phase 2
GlaxoSmithKline
2026–2027
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Site PI · Recruiting · Phase 3
Crystalys Therapeutics
2025–2027